Published in Blood on December 01, 1999
Membrane vesicles as conveyors of immune responses. Nat Rev Immunol (2009) 14.72
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A (2011) 10.56
Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol (2013) 10.02
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci (2011) 5.42
Cells release prions in association with exosomes. Proc Natl Acad Sci U S A (2004) 5.17
Exosome function: from tumor immunology to pathogen biology. Traffic (2008) 4.50
Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J Cell Biol (2006) 4.33
Biogenesis and function of multivesicular bodies. Annu Rev Cell Dev Biol (2007) 4.08
Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol (2006) 3.59
The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One (2012) 3.14
Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One (2010) 3.14
Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles (2015) 3.02
Microvesicles as mediators of intercellular communication in cancer--the emerging science of cellular 'debris'. Semin Immunopathol (2011) 2.78
Platelet alpha-granules: basic biology and clinical correlates. Blood Rev (2009) 2.72
Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res (2005) 2.72
Exosomes: immune properties and potential clinical implementations. Semin Immunopathol (2010) 2.60
Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J Proteome Res (2008) 2.41
MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome. Gut (2009) 2.39
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med (2005) 2.26
Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol (2009) 2.26
Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br J Cancer (2005) 2.17
Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells (2012) 2.14
Nanostructural and transcriptomic analyses of human saliva derived exosomes. PLoS One (2010) 2.11
Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles (2014) 2.11
Microvesicles and viral infection. J Virol (2011) 2.10
Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol Cell Proteomics (2009) 2.08
Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. FASEB J (2009) 2.07
Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation. J Extracell Vesicles (2012) 2.06
Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription. Exp Hematol (2010) 2.01
Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors. Proc Natl Acad Sci U S A (2004) 1.98
Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia (2007) 1.97
Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res (2010) 1.96
Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. Blood (2006) 1.95
Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem (2014) 1.92
Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation. Stem Cells (2007) 1.92
Intercellular transport of microRNAs. Arterioscler Thromb Vasc Biol (2013) 1.84
Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood (2008) 1.83
Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J (2009) 1.78
The α-granule proteome: novel proteins in normal and ghost granules in gray platelet syndrome. J Thromb Haemost (2010) 1.73
The roles of tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol (2011) 1.67
Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS One (2012) 1.67
Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics (2015) 1.65
Paracrine induction of endothelium by tumor exosomes. Lab Invest (2009) 1.63
Prospects for exosomes in immunotherapy of cancer. J Cell Mol Med (2006) 1.63
Tetraspanins in extracellular vesicle formation and function. Front Immunol (2014) 1.56
Role of exosomes/microvesicles in the nervous system and use in emerging therapies. Front Physiol (2012) 1.49
Collective cell migration requires vesicular trafficking for chemoattractant delivery at the trailing edge. J Cell Biol (2008) 1.48
Exosomes derived from mesenchymal stem cells. Int J Mol Sci (2014) 1.43
Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol (2010) 1.43
Active tissue factor pathway inhibitor is expressed on the surface of coated platelets. Blood (2006) 1.39
Emission of membrane vesicles: roles in complement resistance, immunity and cancer. Springer Semin Immunopathol (2005) 1.39
Anchorage-independent growth of breast carcinoma cells is mediated by serum exosomes. Exp Cell Res (2009) 1.36
Extracellular vesicles: emerging targets for cancer therapy. Trends Mol Med (2014) 1.35
The paradoxical dynamism of marrow stem cells: considerations of stem cells, niches, and microvesicles. Stem Cell Rev (2008) 1.34
Role of exosomes in immune regulation. J Cell Mol Med (2006) 1.29
P2X7 receptor regulation of non-classical secretion from immune effector cells. Cell Microbiol (2012) 1.28
Mechanisms and function of dendritic exocytosis. Neuron (2011) 1.28
Differential fates of biomolecules delivered to target cells via extracellular vesicles. Proc Natl Acad Sci U S A (2015) 1.27
Platelet-derived exosomes induce endothelial cell apoptosis through peroxynitrite generation: experimental evidence for a novel mechanism of septic vascular dysfunction. Crit Care (2007) 1.26
Exosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes. Mol Cell Proteomics (2012) 1.26
HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals. AIDS Res Hum Retroviruses (2010) 1.26
Exovesicles from human activated dendritic cells fuse with resting dendritic cells, allowing them to present alloantigens. Am J Pathol (2006) 1.25
Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. Stem Cells (2012) 1.23
Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Semin Cell Dev Biol (2015) 1.23
Stem cell plasticity revisited: the continuum marrow model and phenotypic changes mediated by microvesicles. Exp Hematol (2010) 1.22
Cellular phenotype switching and microvesicles. Adv Drug Deliv Rev (2010) 1.21
Platelets and platelet-like particles mediate intercellular RNA transfer. Blood (2012) 1.20
Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun (2015) 1.20
Exosomes and other extracellular vesicles in host-pathogen interactions. EMBO Rep (2014) 1.19
Ectosomes as modulators of inflammation and immunity. Clin Exp Immunol (2010) 1.19
Progenitor/stem cell fate determination: interactive dynamics of cell cycle and microvesicles. Stem Cells Dev (2012) 1.19
Characterizing blood microparticles: technical aspects and challenges. Vasc Health Risk Manag (2008) 1.17
Regulation of membrane trafficking and subcellular organization of endocytic compartments revealed with FM1-43 in resting and activated human T cells. Exp Cell Res (2003) 1.16
The role of microvesicles in tissue repair. Organogenesis (2011) 1.15
Major histocompatibility complex class II presentation of cell-associated antigen is mediated by CD8alpha+ dendritic cells in vivo. J Exp Med (2002) 1.15
Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes. Oncogene (2014) 1.14
Circulating microparticles: square the circle. BMC Cell Biol (2013) 1.14
Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Thromb Haemost (2008) 1.12
CD45 immunoaffinity depletion of vesicles from Jurkat T cells demonstrates that exosomes contain CD45: no evidence for a distinct exosome/HIV-1 budding pathway. Retrovirology (2008) 1.10
Proteomic and functional characterisation of platelet microparticle size classes. Thromb Haemost (2009) 1.08
How stem cells speak with host immune cells in inflammatory brain diseases. Glia (2013) 1.08
Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (SOMAscan™) platform. Mol Cell Proteomics (2014) 1.08
Isolation and characterization of platelet-derived extracellular vesicles. J Extracell Vesicles (2014) 1.07
Platelet-derived exosomes from septic shock patients induce myocardial dysfunction. Crit Care (2007) 1.07
Stable cell fate changes in marrow cells induced by lung-derived microvesicles. J Extracell Vesicles (2012) 1.07
Pathologic function and therapeutic potential of exosomes in cardiovascular disease. Biochim Biophys Acta (2014) 1.06
Intercellular transfer of MHC and immunological molecules: molecular mechanisms and biological significance. Am J Transplant (2007) 1.06
Plasma miRNA as biomarkers for assessment of total-body radiation exposure dosimetry. PLoS One (2011) 1.05
Tumor-derived exosomes in oncogenic reprogramming and cancer progression. Cell Mol Life Sci (2014) 1.02
P2X7 receptors regulate multiple types of membrane trafficking responses and non-classical secretion pathways. Purinergic Signal (2009) 1.02
Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications. Mol Ther (2015) 1.02
Cellular phenotype and extracellular vesicles: basic and clinical considerations. Stem Cells Dev (2014) 1.00
Role of mesenchymal stem cell-derived microvesicles in tissue repair. Pediatr Nephrol (2013) 1.00
Active uptake of dendritic cell-derived exovesicles by epithelial cells induces the release of inflammatory mediators through a TNF-alpha-mediated pathway. Am J Pathol (2009) 0.99
Exosomal membrane molecules are potent immune response modulators. Commun Integr Biol (2010) 0.99
Different types of in vitro generated human monocyte-derived dendritic cells release exosomes with distinct phenotypes. Immunology (2007) 0.98
Cryo-electron microscopy of extracellular vesicles in fresh plasma. J Extracell Vesicles (2013) 0.98
Emerging roles of extracellular vesicles in the adaptive response of tumour cells to microenvironmental stress. J Extracell Vesicles (2013) 0.97
Characterization of membrane-shed microvesicles from cytokine-stimulated β-cells using proteomics strategies. Mol Cell Proteomics (2012) 0.97
Exosomal miRNAs as potential biomarkers of cardiovascular risk in children. J Transl Med (2014) 0.96
B lymphocytes secrete antigen-presenting vesicles. J Exp Med (1996) 11.53
A new method of preparing gold probes for multiple-labeling cytochemistry. Eur J Cell Biol (1985) 10.51
Immuno-localization of the insulin regulatable glucose transporter in brown adipose tissue of the rat. J Cell Biol (1991) 8.67
The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell (1996) 8.25
Intracellular site of asialoglycoprotein receptor-ligand uncoupling: double-label immunoelectron microscopy during receptor-mediated endocytosis. Cell (1983) 6.89
Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature (1991) 5.90
Synaptic assembly of the brain in the absence of neurotransmitter secretion. Science (2000) 5.89
Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem (1998) 5.79
Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci (2000) 5.57
Improving structural integrity of cryosections for immunogold labeling. Histochem Cell Biol (1996) 4.73
Procollagen traverses the Golgi stack without leaving the lumen of cisternae: evidence for cisternal maturation. Cell (1998) 4.67
Use of colloidal gold particles in double-labeling immunoelectron microscopy of ultrathin frozen tissue sections. J Cell Biol (1981) 4.33
Sizing of protein A-colloidal gold probes for immunoelectron microscopy. J Cell Biol (1981) 4.32
The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell (1990) 4.18
Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med (1991) 4.15
A novel class of clathrin-coated vesicles budding from endosomes. J Cell Biol (1996) 4.05
Intracellular receptor sorting during endocytosis: comparative immunoelectron microscopy of multiple receptors in rat liver. Cell (1984) 3.96
The autophagic and endocytic pathways converge at the nascent autophagic vacuoles. J Cell Biol (1997) 3.77
Possible pathways for lysosomal enzyme delivery. J Cell Biol (1985) 3.25
Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium. Nature (1979) 3.06
Transport from late endosomes to lysosomes, but not sorting of integral membrane proteins in endosomes, depends on the vacuolar proton pump. J Cell Biol (1995) 3.03
Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat. Proc Natl Acad Sci U S A (1991) 2.91
CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem (1991) 2.82
Membranes of sorting organelles display lateral heterogeneity in receptor distribution. J Cell Biol (1987) 2.59
Late endosomes derive from early endosomes by maturation. Cell (1991) 2.41
Vesicular tubular clusters between the ER and Golgi mediate concentration of soluble secretory proteins by exclusion from COPI-coated vesicles. Cell (1999) 2.40
Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). Proc Natl Acad Sci U S A (2000) 2.40
Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. J Immunol (2000) 2.36
Lack of discriminating signs and symptoms in clinical diagnosis of influenza of patients admitted to the hospital. Infection (2007) 2.35
Beta-COP localizes mainly to the cis-Golgi side in exocrine pancreas. J Cell Biol (1993) 2.33
Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature (1986) 2.31
Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease. Nat New Biol (1972) 2.30
Recycling compartments and the internal vesicles of multivesicular bodies harbor most of the cholesterol found in the endocytic pathway. Traffic (2003) 2.30
Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding. J Virol (1994) 2.27
Sorting of endocytosed transferrin and asialoglycoprotein occurs immediately after internalization in HepG2 cells. J Cell Biol (1987) 2.25
Differences in the endosomal distributions of the two mannose 6-phosphate receptors. J Cell Biol (1993) 2.25
Mannose 6-phosphate receptors are sorted from immature secretory granules via adaptor protein AP-1, clathrin, and syntaxin 6-positive vesicles. J Cell Biol (1998) 2.24
Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment. J Thromb Haemost (2003) 2.12
The pathways of endocytosed transferrin and secretory protein are connected in the trans-Golgi reticulum. J Cell Biol (1988) 2.12
Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. Blood (2000) 2.12
Intracellular trafficking of lysosomal membrane proteins. Bioessays (1996) 2.09
Ultrastructural localization of the mannose 6-phosphate receptor in rat liver. J Cell Biol (1984) 2.08
Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science (1994) 2.08
39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein. EMBO J (1995) 1.98
Vesicular stomatitis virus glycoprotein, albumin, and transferrin are transported to the cell surface via the same Golgi vesicles. J Cell Biol (1983) 1.94
Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial. Ann Intern Med (1995) 1.93
Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules. Blood (1998) 1.88
Molecules relevant for T cell-target cell interaction are present in cytolytic granules of human T lymphocytes. Eur J Immunol (1989) 1.88
Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells. J Cell Biol (2001) 1.87
Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells. J Cell Biol (1992) 1.86
Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells. Cell (1991) 1.81
How MHC class II molecules reach the endocytic pathway. EMBO J (1995) 1.80
Insulin-induced translocation of glucose transporters from post-Golgi compartments to the plasma membrane of 3T3-L1 adipocytes. J Cell Biol (1988) 1.78
Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications? Am J Gastroenterol (2000) 1.78
Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments. J Cell Biol (1997) 1.75
Relations between the intracellular pathways of the receptors for transferrin, asialoglycoprotein, and mannose 6-phosphate in human hepatoma cells. J Cell Biol (1989) 1.74
Peri-Golgi vesicles contain retrograde but not anterograde proteins consistent with the cisternal progression model of intra-Golgi transport. J Cell Biol (2001) 1.73
The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules. J Immunol (1998) 1.69
Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis. J Exp Med (1992) 1.68
Molecular immunocytochemistry of the CuZn superoxide dismutase in rat hepatocytes. J Cell Biol (1988) 1.68
Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura. J Thromb Haemost (2006) 1.68
Primaquine interferes with membrane recycling from endosomes to the plasma membrane through a direct interaction with endosomes which does not involve neutralisation of endosomal pH nor osmotic swelling of endosomes. Eur J Cell Biol (2000) 1.64
Immunoelectron microscopic localization of acidic intracellular compartments in hepatoma cells. EMBO J (1985) 1.64
von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura. Blood (1999) 1.62
Functional and ultrastructural evidence for intracellular formation of major histocompatibility complex class II-peptide complexes during antigen processing. Proc Natl Acad Sci U S A (1990) 1.60
Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells. J Exp Med (1995) 1.60
Structure-function relationship of human von Willebrand factor. Blood (1987) 1.60
Influence of aldehyde fixation on the morphology of endosomes and lysosomes: quantitative analysis and electron tomography. J Microsc (2003) 1.59
The tyrosine-based lysosomal targeting signal in lamp-1 mediates sorting into Golgi-derived clathrin-coated vesicles. EMBO J (1996) 1.58
Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood. Arteriosclerosis (1989) 1.57
Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes. J Exp Med (1995) 1.57
Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli. J Exp Med (2000) 1.56
The differential degradation of two cytosolic proteins as a tool to monitor autophagy in hepatocytes by immunocytochemistry. J Cell Biol (1993) 1.55
Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation (1999) 1.54
Increased thromboxane biosynthesis in patients with acute cerebral ischemia. Stroke (1993) 1.54
Immunocytochemical and biochemical studies of GLUT4 in rat skeletal muscle. J Biol Chem (1992) 1.53
Concordance of phenprocoumon dosage in married couples. BMJ (1997) 1.51
Immunogenic peptides bind to class II MHC molecules in an early lysosomal compartment. J Immunol (1993) 1.51
Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi. Nature (1992) 1.50
Cyclosporine is associated with endothelial dysfunction but not with platelet activation in renal transplantation. Neth J Med (2001) 1.50
Antibodies that stop the adrenals in their tracks. Lancet (2001) 1.48
Identification of subcellular compartments involved in biosynthetic processing of cathepsin D. J Biol Chem (1992) 1.48
Endosomal compartmentalization in three dimensions: implications for membrane fusion. Proc Natl Acad Sci U S A (2003) 1.47
Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women. Circulation (2000) 1.45
A new model for lethal hit delivery by cytotoxic T lymphocytes. Immunol Today (1990) 1.45
Disproportional immunostaining patterns of two secretory proteins in guinea pig and rat exocrine pancreatic cells. An immunoferritin and fluorescence study. Eur J Cell Biol (1980) 1.44
A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med (1983) 1.44
Immunocytochemical localization of the receptor for asialoglycoprotein in rat liver cells. J Cell Biol (1982) 1.40
Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III. J Clin Invest (1985) 1.40
Cell biology of the asialoglycoprotein receptor system: a model of receptor-mediated endocytosis. Int Rev Cytol (1985) 1.39
[Thrombotic thrombocytopenic purpura: a benign disease with a very severe acute phase]. Ned Tijdschr Geneeskd (1990) 1.39
The role of collagen in thrombosis and hemostasis. J Thromb Haemost (2004) 1.38
Mannose 6-phosphate-independent membrane association of cathepsin D, glucocerebrosidase, and sphingolipid-activating protein in HepG2 cells. J Biol Chem (1991) 1.37
von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation. Blood (1999) 1.36
Subcellular localization of Forssman glycolipid in epithelial MDCK cells by immuno-electronmicroscopy after freeze-substitution. J Cell Biol (1991) 1.36
GLUT-4 NH2 terminus contains a phenylalanine-based targeting motif that regulates intracellular sequestration. J Cell Biol (1993) 1.35
Transport and intracellular distribution of MHC class II molecules and associated invariant chain in normal and antigen-processing mutant cell lines. J Cell Biol (1994) 1.34
No evidence for expression of the insulin-regulatable glucose transporter in endothelial cells. Nature (1990) 1.32